Clinical Scorecard: Impact of Metabolic Syndrome on Severe Maternal Morbidity in Older Pregnant Patients

At a Glance

Key Highlights

• Metabolic syndrome is the strongest independent predictor of SMM among advanced maternal age patients, with a threefold increase in odds.
• Routine screening for MetS components is recommended for better risk stratification in this population.
• Advanced maternal age is associated with higher rates of chronic conditions that increase SMM risk.
• SMM is multifactorial, influenced by chronic conditions, substance use, and sociodemographic factors.

Guideline-Based Recommendations

Diagnosis

• Incorporate preconception and prenatal screening for metabolic syndrome components.

Management

• Refer patients with MetS for higher-level obstetric management and include lifestyle modifications.

Monitoring & Follow-up

• Monitor for indicators of severe maternal morbidity during pregnancy and delivery.

Risks

• Increased risk of severe maternal morbidity associated with metabolic syndrome and advanced maternal age.

Patient & Prescribing Data

Pregnant individuals aged ≥ 35 years with metabolic syndrome.

Focus on managing chronic conditions such as hypertension, diabetes, and obesity with specific treatment options.

Clinical Best Practices

• Utilize CDC-defined indicators for assessing severe maternal morbidity.
• Exclude pregnancy-related conditions from the definition of metabolic syndrome.
• Employ multivariable logistic regression for analyzing risk factors associated with SMM.
• Add evidence-based practices for screening and monitoring MetS in pregnant patients.

References

• CDC Severe Maternal Morbidity Indicators
• National Inpatient Sample
• Healthcare Cost and Utilization Project